Neurofilament light levels are associated with long-term outcomes in multiple sclerosis

BACKGROUND: Neurofilament light chain (NfL) is a promising marker of disease activity/treatment response in multiple sclerosis (MS), although its predictive value for long-term clinical outcomes remains unclear. OBJECTIVE: We measured NfL from a phase 3 trial in relapsing-remitting MS and investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuhle, Jens, Plavina, Tatiana, Barro, Christian, Disanto, Giulio, Sangurdekar, Dipen, Singh, Carol M, de Moor, Carl, Engle, Bob, Kieseier, Bernd C, Fisher, Elizabeth, Kappos, Ludwig, Rudick, Richard A, Goyal, Jaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604552/
https://www.ncbi.nlm.nih.gov/pubmed/31680621
http://dx.doi.org/10.1177/1352458519885613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604552/
https://www.ncbi.nlm.nih.gov/pubmed/31680621
http://dx.doi.org/10.1177/1352458519885613

Ejemplares similares